Adaptive Biotechnologies Corp. (ADPT)
18.26
+2.50
(+15.83%)
USD |
NASDAQ |
Jan 12, 16:00
18.00
-0.26
(-1.40%)
After-Hours: 17:19
Adaptive Biotechnologies Research and Development Expense (Quarterly): 20.92M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Zymeworks, Inc. | 35.58M |
| Cue Biopharma, Inc. | 4.686M |
| Recursion Pharmaceuticals, Inc. | 107.66M |
| Arcellx, Inc. | 35.09M |